NCT03731845View on ClinicalTrials.gov

Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

October 31, 2026

Study Completion Date

January 31, 2027

Conditions
Breast Cancer
Interventions
GENETIC

Blood sample for genetic test

Patients will be genotyped for single nucleotide polymorphism previously found to be associated with age at natural menopause

BIOLOGICAL

Blood sample for hormonal measurement

at each visit : 2x7ml. At the end of the study hormonal measurements (AMH, P4, LH, FSH, E25)

OTHER

Ovarian ultrasound scan

Ovarian ultrasound scan at follow up visits (Y1,Y1.5, Y2.5 Y3.5 Y4.5 Y5.5)

Trial Locations (1)

92140

Antoine Béclère Hospital, Clamart

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03731845 - Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer | Biotech Hunter | Biotech Hunter